Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TILE | US
-0.05
-0.28%
Consumer Cyclical
Textile Manufacturing
30/06/2024
04/10/2024
18.13
18.13
18.24
17.94
Interface Inc. designs produces and sells modular carpet products primarily in the United States and internationally. The company operates in two segments Americas (AMS) and Europe Africa Asia and Australia (EAAA). The company offers modular carpets under the Interface and FLOR brand names; luxury vinyl tiles and vinyl sheet under the Interface brand; carpet tiles under the CQuestGB name for use in commercial interiors include offices healthcare facilities airports educational and other institutions hospitality spaces and retail facilities as well as residential interiors; and modular resilient flooring products. It also provides carpet replacement installation and maintenance services; and rubber flooring under the norament and noraplan brand names. The company produces and sells an adapted version of its carpet tile for the healthcare facilities market. In addition it sells a proprietary antimicrobial chemical compound under the Intersept name; sells TacTiles a carpet tile installation system as well as various adhesives and products; and provides turnkey project management services for global accounts and other customers through its InterfaceSERVICES business. The company sells its products directly to end-users as well as indirectly through independent contractors installers or distributors. Interface Inc. was incorporated in 1973 and is headquartered in Atlanta Georgia.
View LessValue Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
25.7%1 month
26.2%3 months
36.2%6 months
37.9%16.28
13.28
2.38
1.06
0.39
8.72
1.14
0.89
171.17M
1.06B
1.06B
0.22
10.72
41.40
5.20
15.83
4.36
4.06
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.51
Range1M
2.03
Range3M
5.33
Rel. volume
0.96
Price X volume
11.92M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Owens & Minor Inc | OMI | Medical Distribution | 14.68 | 1.13B | -0.68% | n/a | 277.21% |
OPKO Health Inc | OPK | Drug Manufacturers-Specialty & Generic | 1.49 | 1.03B | -1.97% | n/a | 19.31% |
Evolus Inc | EOLS | Drug Manufacturers-Specialty & Generic | 16.34 | 1.03B | -4.67% | n/a | 656.27% |
PetIQ Inc | PETQ | Drug Manufacturers-Specialty & Generic | 30.87 | 923.02M | 0.13% | 83.11 | 178.54% |
Phibro Animal Health Corporation | PAHC | Drug Manufacturers-Specialty & Generic | 21.31 | 863.13M | -2.07% | 367.83 | 204.74% |
Pacira Pharmaceuticals Inc | PCRX | Drug Manufacturers-Specialty & Generic | 16.515 | 761.79M | 6.34% | 10.85 | 73.76% |
Ironwood Pharmaceuticals Inc | IRWD | Drug Manufacturers-Specialty & Generic | 4.3 | 693.71M | 0.94% | 50.25 | -199.01% |
Radius Health Inc | RDUS | Drug Manufacturers-Specialty & Generic | 17.9 | 506.39M | -4.48% | n/a | 0.00% |
Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 4.42 | 495.19M | 0.00% | n/a | 117.00% |
Aquestive Therapeutics Inc | AQST | Drug Manufacturers-Specialty & Generic | 4.95 | 450.75M | 3.34% | n/a | -329.45% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 8.72 | - | - |
Ent. to Revenue | 1.14 | - | - |
PE Ratio | 16.28 | - | - |
Price to Book | 2.38 | - | - |
Dividend Yield | 0.22 | - | - |
Std. Deviation (3M) | 36.21 | - | - |
Debt to Equity | 1.06 | - | - |
Debt to Assets | 0.39 | - | - |
Market Cap | 1.06B | - | - |